Horizon Therapeutics Public (HZNP) News Today → You didn’t listen then so you must now (From Porter & Company) (Ad) Free HZNP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 27, 2024 | finance.yahoo.comHorizon Therapeutics Public Lim (HZNP)December 21, 2023 | seekingalpha.com5 Biotech Acquisition Targets To Accumulate In 2024November 16, 2023 | msn.comNasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business CombinationOctober 24, 2023 | chicago.suntimes.comHorizon Therapeutics cut jobs in Deerfield after Amgen acquisitionOctober 24, 2023 | msn.com350 Horizon Therapeutics workers to be laid off, mostly from Deerfield offices, following acquisition by AmgenOctober 14, 2023 | marketbeat.comCongress Asset Management Co. MA Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Congress Asset Management Co. MA lessened its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 80.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,645 shares of theOctober 13, 2023 | marketbeat.comTokio Marine Asset Management Co. Ltd. Has $10.94 Million Stock Holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Tokio Marine Asset Management Co. Ltd. cut its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 41.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 106,400 shares of the biopharmaceuticOctober 11, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Purchased by National Bank of Canada FINational Bank of Canada FI lifted its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 1,042.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 219,042 shares of the biopharmacOctober 10, 2023 | marketbeat.comState of Alaska Department of Revenue Sells 23,645 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)State of Alaska Department of Revenue lowered its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 36.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,511 shares of the biopharmaceutical coOctober 9, 2023 | marketbeat.comDekaBank Deutsche Girozentrale Purchases 11,882 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)DekaBank Deutsche Girozentrale increased its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 8.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,October 6, 2023 | marketbeat.comOlympiad Research LP Has $1.84 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Olympiad Research LP raised its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 30.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,857 shares of the biopharmaceuticalOctober 6, 2023 | finance.yahoo.comRule 17(e) Announcement - Horizon Therapeutics plcOctober 6, 2023 | marketbeat.comHorizon Therapeutics Public (NASDAQ:HZNP) Research Coverage Started at StockNews.comStockNews.com started coverage on shares of Horizon Therapeutics Public in a research report on Thursday. They set a "strong-buy" rating on the stock.October 6, 2023 | marketbeat.comTrading was temporarily halted for "HZNP" at 07:10 PM with a stated reason of "News pending."October 5, 2023 | stocknews.com3 Pharma Stocks With Potential to Outperform Pfizer Inc. (PFE) in OctoberOctober 5, 2023 | stockhouse.comRule 17(d) Announcement - Horizon Therapeutics plcOctober 5, 2023 | finance.yahoo.comRule 17(d) Announcement – Horizon Therapeutics plcOctober 4, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC cut its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 96.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,318 shares of the bOctober 2, 2023 | finance.yahoo.comHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023September 26, 2023 | benzinga.comBoard Member at Horizon Therapeutics Exercises Options Worth $2.31MSeptember 26, 2023 | finance.yahoo.comHorizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care IndustrySeptember 24, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by Congress Wealth Management LLC DECongress Wealth Management LLC DE reduced its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 84.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,136 shares of tSeptember 21, 2023 | marketbeat.comPalliser Capital UK Ltd Has $8.17 Million Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Palliser Capital UK Ltd lessened its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 4.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,460 shares of the biopharmaSeptember 19, 2023 | finance.yahoo.comHorizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 ListSeptember 19, 2023 | finance.yahoo.comHealth care: FTC Chair Lina Khan to crack down on 'below radar' dealsSeptember 17, 2023 | marketbeat.comAtria Wealth Solutions Inc. Sells 2,756 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)Atria Wealth Solutions Inc. trimmed its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 31.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,998 shares ofSeptember 15, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Syquant Capital Sas' Largest PositionSyquant Capital Sas grew its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 214.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 853,166 shares of the biopharmaceutical compSeptember 13, 2023 | finance.yahoo.comQ32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia AreataSeptember 13, 2023 | marketbeat.comHorizon Therapeutics Public (NASDAQ:HZNP) Upgraded by StockNews.com to Strong-BuyStockNews.com raised Horizon Therapeutics Public from a "buy" rating to a "strong-buy" rating in a research note on Wednesday.September 12, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Governors Lane LP's 2nd Largest PositionGovernors Lane LP grew its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 193.8% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 451,800 shares of the biopharmaceutical company's stock after purchasing an additionalSeptember 8, 2023 | marketbeat.comRenaissance Technologies LLC Purchases 1,693,400 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)Renaissance Technologies LLC raised its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 101.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,368,449 shares of the biopharmaceutSeptember 7, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Prosight Management LP's 9th Largest PositionProsight Management LP lowered its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 10.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,035 shares ofSeptember 6, 2023 | marketbeat.com3 Growth Stocks to Buy in September (HZNP)As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earningsSeptember 5, 2023 | finance.yahoo.comHorizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of ArrangementSeptember 5, 2023 | marketbeat.comOxford Financial Group Ltd. Invests $273,000 in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Oxford Financial Group Ltd. bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,500 shares of the biopharmaceuticalSeptember 5, 2023 | marketbeat.comStockNews.com Lowers Horizon Therapeutics Public (NASDAQ:HZNP) to BuyStockNews.com lowered Horizon Therapeutics Public from a "strong-buy" rating to a "buy" rating in a research report on Tuesday.September 4, 2023 | benzinga.comHere's How Much $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth TodaySeptember 3, 2023 | marketbeat.com27,842 Shares in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Purchased by FORA Capital LLCFORA Capital LLC acquired a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 27,842 shares of the biopharmaceutical company's stock,September 1, 2023 | finanznachrichten.deHorizon Therapeutics plc and Amgen: Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close AcquisitionSeptember 1, 2023 | marketbeat.comAllspring Global Investments Holdings LLC Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Allspring Global Investments Holdings LLC cut its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 58.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 79,375 shares of the biopharmaceutiSeptember 1, 2023 | marketbeat.comShort Interest in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Decreases By 7.7%Horizon Therapeutics Public Limited (NASDAQ:HZNP - Get Free Report) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 7,860,000 shares, a drop of 7.7% from the July 31st total of 8,520,000 shares. Currently, 3.5% of the company's stock are short sold. Based on an average trading volume of 1,610,000 shares, the short-interest ratio is presently 4.9 days.September 1, 2023 | marketbeat.comHorizon Therapeutics Public (NASDAQ:HZNP) Downgraded to Hold at Jefferies Financial GroupJefferies Financial Group lowered Horizon Therapeutics Public from a "buy" rating to a "hold" rating in a research report on Friday.September 1, 2023 | marketbeat.comHow Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (HZNP)Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.September 1, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Given Consensus Recommendation of "Hold" by BrokeragesShares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are currently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation.August 28, 2023 | finance.yahoo.comFTC suspends challenge to Amgen-Horizon Therapeutics dealAugust 26, 2023 | reuters.comUS FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon TherapeuticsAugust 25, 2023 | marketbeat.comRamius Advisors LLC Purchases Shares of 141,528 Horizon Therapeutics Public Limited (NASDAQ:HZNP)Ramius Advisors LLC acquired a new stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 141,528 shares of the biopharmaceutical company's stock, valued at appAugust 23, 2023 | finance.yahoo.comHorizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy GroupsAugust 23, 2023 | marketbeat.comKnott David M Jr Acquires 1,000 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)Knott David M Jr lifted its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,490 shares of thAugust 22, 2023 | marketbeat.comCredit Suisse AG Has $40.85 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Credit Suisse AG boosted its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 3.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 374,293 shares of the biopharmaceutical company's stock Get Horizon Therapeutics Public News Delivered to You Automatically Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market… Click here for the details HZNP Media Mentions By Week HZNP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HZNP News Sentiment▼0.000.82▲Average Medical News Sentiment HZNP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HZNP Articles This Week▼02▲HZNP Articles Average Week Get Horizon Therapeutics Public News Delivered to You Automatically Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RPRX News JAZZ News MRTX News ZTS News BMY News GMAB News ALNY News TEVA News BGNE News BMRN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HZNP) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Clinton Backing Biden Replacement???The Freeport SocietyDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Therapeutics Public Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
